Subscribe to RSS
DOI: 10.1055/s-0029-1202348
© Georg Thieme Verlag KG Stuttgart · New York
Fatty Acid Oxidation is Decreased in the Liver of Ovariectomized Rats
Publication History
received 05.08.2008
accepted 07.01.2009
Publication Date:
24 February 2009 (online)

Abstract
Estrogen-deficient states are associated with hepatic steatosis. Based on previous findings obtained at the molecular and enzymatic levels, it has been suggested that estradiol exerts its lipid-lowering effects in liver through partitioning of triacylglycerols into oxidative pathways. However, information on relevant physiological response was lacking. Therefore, the purpose of the present study was to assess fatty acid oxidation rate in the liver of intact and ovariectomized rats. Tritiated water released from liver slices incubated with 9,10-[3H]palmitate was measured as a reflection of in vivo fatty acid metabolism. Fatty acid oxidation rate was lowered by 34% (p<0.05), associated with 114% higher (p<0.01) hepatic triacylgylcerol content in the liver of ovariectomized as compared to intact rats. Estrogen replacement prevented all of these changes. Fatty liver has been linked with hepatic leptin resistance in obese male rats. Since leptin stimulates fatty acid oxidation in liver, we hypothesized that increased liver triacylglycerol content and decreased fatty acid oxidation might be associated with leptin resistance in ovariectomized rats. To this end, acute leptin delivery was performed. The 120-min intravenous leptin infusion increases fatty acid oxidation by 23% in the liver of ovariectomized rats, which was coupled with 24% lower hepatic triacylglycerol content. We conclude that fatty acid oxidation is decreased in the liver of ovariectomized rats, which is likely to contribute to hepatic steatosis development. Furthermore, our results suggest that leptin sensitivity is not completely lost in the liver of rats ovariectomized for 5 weeks.
Key words
lipid oxidation - fatty liver - fatty acid metabolism - leptin - menopause
References
- 1
Qureshi K, Abrams GA.
Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis
of nonalcoholic fatty liver disease.
World J Gastroenterol.
2007;
13
3540-3553
MissingFormLabel
- 2
Nguyen P, Leray V, Diez M, Serisier S, Le Bloc’h J, Siliart B, Dumon H.
Liver lipid metabolism.
J Anim Physiol Anim Nutr.
2008;
92
272-283
MissingFormLabel
- 3
Völzke H, Schwarz S, Baumeister SE, Wallaschofski H, Schwahn C, Grabe HJ, Kohlmann T, John U, Dören M.
Menopausal status and hepatic steatosis in a general female population.
Gut.
2007;
56
594-595
MissingFormLabel
- 4
Hewitt KN, Pratis K, Jones MEE, Simpson ER.
Estrogen replacement reverses the hepatic steatosis phenotype in the male aromatase
knockout mouse.
Endocrinology.
2004;
145
1842-1848
MissingFormLabel
- 5
Lemieux C, Phaneuf D, Labrie F, Giguère V, Richard D, Deshaies Y.
Estrogen receptor α-mediated adiposity-lowering and hypocholesterolemic actions of
the selective estrogen receptor modulator acolbifen.
Int J Obes (Lond).
2005;
29
1236-1244
MissingFormLabel
- 6
Deshaies Y, Dagnault A, Lalonde J, Richard D.
Interaction of corticosterone and gonadal steroids on lipid deposition in the female
rat.
Am J Physiol Endocrinol Metab.
1997;
273
E355-E362
MissingFormLabel
- 7
Paquette A, Shinoda M, Rabasa-Lhoret R, Prud’homme D, Lavoie JM.
Time course of liver lipid infiltration in ovariectomized rats: impact of a high-fat
diet.
Maturitas.
2007;
58
182-190
MissingFormLabel
- 8
D’Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS.
Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic
regulation of lipogenic and oxidative pathways.
J Biol Chem.
2005;
280
35983-35991
MissingFormLabel
- 9
Paquette A, Wang D, Jankowski M, Gutkowska J, Lavoie JM.
Effects of ovariectomy on PPARα, SREBP-1c, and SCD-1 gene expression in the rat liver.
Menopause.
2008;
15
1169-1175
MissingFormLabel
- 10
Desvergne B, Wahli W.
Peroxisome proliferator-activated receptors: Nuclear control of metabolism.
Endocr Rev.
1999;
20
649-688
MissingFormLabel
- 11
Campbell SE, Mehan KA, Tunstall RJ, Febbraio MA, Cameron-Smith D.
17β-estradiol upregulates the expression of peroxisome proliferator-activated receptor
α and lipid oxidative genes in skeletal muscle.
J Mol Endocrinol.
2003;
31
37-45
MissingFormLabel
- 12
Campbell SE, Febbraio MA.
Effect of ovarian hormones on mitochondrial enzyme activity in the fat oxidation pathway
of skeletal muscle.
Am J Endocrinol Metab.
2001;
281
E803-E808
MissingFormLabel
- 13
Toda K, Takeda K, Akira S, Saibara T, Okada T, Onishi S, Shizuta Y.
Alternations in hepatic expression of fatty-acid metabolizing enzymes in ArKO mice
and their reversal by the treatment with 17 β-estradiol or a peroxisome proliferator.
J Steroid Biochem Mol Biol.
2001;
79
11-17
MissingFormLabel
- 14
Huang W, Dedousis N, Bandi A, Lopaschuk GD, O’Doherty RM.
Liver triglyceride secretion and lipid oxidative metabolism are rapidly altered by
leptin in vivo.
Endocrinology.
2006;
147
1480-1487
MissingFormLabel
- 15
Huang W, Dedousis N, Bhatt BA, O’Doherty M.
Impaired activation of phosphatidylinositol 3-kinase by leptin is a novel mechanism
of hepatic leptin resistance in diet-induced obesity.
J Biol Chem.
2004;
279
21695-21700
MissingFormLabel
- 16
Fishman S, Muzumdar RH, Atzmon G, Ma X, Yang X, Einstein FH, Barzilai N.
Resistance to leptin action is the major determinant of hepatic triglyceride accumulation
in vivo.
FASEB J.
2007;
21
53-60
MissingFormLabel
- 17
Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH.
Direct antidiabetic effect of leptin through triglyceride depletion of tissues.
Proc Natl Acad Sci USA.
1997;
94
4637-4641
MissingFormLabel
- 18
Kimura M, Irahara M, Yasui T, Saito S, Tezuka M, Yamano S, Kamada M, Aono T.
The obesity in bilateral ovariectomized rats is related to a decrease in the expression
of leptin receptors in the brain.
Biochem Biophys Res Commun.
2002;
290
1349-1353
MissingFormLabel
- 19
Meli R, Pacilio M, Raso GM, Esposito E, Coppola A, Nasti A, Carlo C Di, Nappi C, Carlo R Di.
Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose
tissue from ovariectomized rats.
Endocrinology.
2004;
145
3115-3121
MissingFormLabel
- 20
Ainslie DA, Morris MJ, Wittert G, Turnbull H, Proietto J, Thorburn AW.
Estrogen deficiency causes central leptin insensitivity and increased hypothalamic
neuropeptide Y.
Int J Obes Relat Metab Disord.
2001;
25
1680-1688
MissingFormLabel
- 21
Robertson MC, Owens RE, Klindt J, Friesen HG.
Ovariectomy leads to a rapid increase in rat placental lactogen secretion.
Endocrinology.
1984;
114
1805-1811
MissingFormLabel
- 22
El-Mas MM, Abdel-Rahman AA.
Effects of long-term ovariectomy and estrogen replacement on clonidine-evoked reductions
in blood pressure and hemodynamic variability.
J Cardiovasc Pharmacol.
2004;
43
607-615
MissingFormLabel
- 23
Bonjorn VM, Latour MG, Bélanger P, Lavoie JM.
Influence of prior exercise and liver glycogen content on the sensitivity of the liver
to glucagon.
J Appl Physiol.
2002;
92
188-194
MissingFormLabel
- 24
Ibrahimi A, Bonen A, Blinn WD, Hajri T, Li X, Zhong K, Cameron R, Abumrad NA.
Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting
muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose
and insulin.
J Biol Chem.
1999;
274
26761-26766
MissingFormLabel
- 25
Louet JF, LeMay C, Mauvais-Jarvis F.
Antidiabetic actions of estrogen: insight from human and genetic mouse models.
Curr Atheroscler Rep.
2004;
6
180-185
MissingFormLabel
- 26
Liu ML, Xu X, Rang WQ, Li YJ, Song HP.
Influence of ovariectomy and 17 β-estradiol treatment on insulin sensitivity, lipid
metabolism and post-ischemic cardiac function.
Int J Cardiol.
2004;
97
485-493
MissingFormLabel
- 27
Tanaka M, Nakaya S, Kumai T, Watanabe M, Tateishi T, Shimizu H, Kobayashi S.
Effects of estrogen on serum leptin levels and leptin mRNA expression in adipose tissue
in rats.
Horm Res.
2001;
56
98-104
MissingFormLabel
- 28
Kim S, Shin HJ, Kim SY, Kim JH, Lee YS, Kim DH, Lee MO.
Genistein enhances expression of genes involved in fatty acid catabolism through activation
of PPARalpha.
Mol Cell Endocrinol.
2004;
31
51-58
MissingFormLabel
- 29
Clegg DJ, Brown LM, Woods SC, Benoit SC.
Gonadal hormones determine sensitivity to central leptin and insulin.
Diabetes.
2006;
55
978-987
MissingFormLabel
- 30
Unger RH.
Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine.
Biochimie.
2005;
87
57-64
MissingFormLabel
- 31
Mystkowski P, Schwartz MW.
Gonadal steroids and energy homeostasis in the leptin era.
Nutrition.
2000;
16
937-946
MissingFormLabel
- 32
Gao Q, Horvath TL.
Cross-talk between estrogen and leptin signaling in the hypothalamus.
Am J Physiol Endocrinol Metab.
2008;
294
E817-E826
MissingFormLabel
Correspondence
A. Paquette
Département de kinésiologie
Université de Montréal
C.P. 6128, Succ. centre-ville
Montréal (Québec)
Canada H3C 3J7
Phone: +1/514/343 61 11 (4867)
Fax: +1/514/343 21 81
Email: amelie.paquette@umontreal.ca